Clinical Study

Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment in Eyes with Proliferative Diabetic Retinopathy

Table 1

Demographic data of patients.

Case numberAge/sex/eyeMH sizeActive/fibroticSeverityDistributionRD extentInitialFinalF/U durationMH closureProcedure

156/M/L500F113ND/50 cm0.035M+2
252/F/R500F2220.10.0515M+2
349/M/R480A1110.050.0512M+2
433/M/R200A2220.040.2512M+2
552/F/L200A3220.050.0516M+2
671/F/R900F1110.10.110M+3
749/F/L200F2110.10.26M+3
863/M/L200F2220.010.055M+3
942/F/L510F2220.050.218M+1
1046/M/L375F2210.10.35M+1

BCVA: best corrected decimal visual acuity; F/U: follow-up; MH: macular hole; M: male; F: female; FVP: fibrovascular proliferation; ERM: epiretinal membrane; RD: retinal detachment; L: left; R: right; ND: number of digits. Procedure: (1) inverted internal limiting membrane (ILM) flaps covering macular hole; (2) inverted ILM flaps insertion; (3) free ILM flaps insertion. Severity scale of FVP: Grade 1: multiple-point adhesions with or without 1 site plaque-like broad adhesion; Grade 2: broad adhesions in more than 1 but fewer than 3 sites, located posterior to the equator; Grade 3: broad adhesions in more than 3 sites, located posterior to the equator or extending beyond the equator within 1 quadrant; Grade 4: broad adhesions extending beyond the equator for more than 1 quadrant. Distribution of fibrous tissue: (1) arcade; (2) arcade and other area. RD extent: extent of retinal detachment—(1) within the arcade; (2) beyond the arcade, within the equator; (3) beyond the equator.